Oligonucleotide Synthesis Market Size Projected to Reach USD

Source Domain: www.openpr.com

Projected Market Growth: The oligonucleotide synthesis market is expected to grow significantly, reaching USD 12.65 billion by 2035, expanding at a compound annual growth rate (CAGR) of 9.95% from 2026 to 2035.
Technological Advancements: The integration of AI in oligonucleotide synthesis is transforming the industry by improving production accuracy, reducing costs, and enhancing the speed of therapeutic development.
Market Segments: Key segments include finished dosage forms, active pharmaceutical ingredients, antisense oligonucleotides, and commercial-scale operations. Different therapeutic areas like rare diseases and cardiovascular disorders contribute to demand.
Regional Insights: North America dominates the market due to a strong biotech ecosystem and significant R&D investments, while Asia Pacific is expected to be the fastest-growing region because of increasing prevalence of genetic disorders and expanding biotech infrastructure.

You may have missed